Why it was recalled
Lack of Assurance of Sterility
Product description
Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1.
Lot numbers, UPCs & expiration codes
Lot#: AE4013, Exp 1/31/2027; AE5032 & AE5039, Exp 3/31/2028; AE5104, Exp 8/31/2028.
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0554-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- May 12, 2026
- FDA report date
- Jun 10, 2026
- Quantity
- 210625 ampules
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Spectra Medical Devices, Llc
Original FDA data
Every field from FDA enforcement report D-0554-2026, exactly as published.
Show all FDA fields
- City
- Wilmington
- State
- MA
- Status
- Ongoing
- Country
- United States
- Event ID
- 98976
- Address
- 299 Ballardvale St
- Address (line 2)
- Ste 1
- Code information
- Lot#: AE4013, Exp 1/31/2027; AE5032 & AE5039, Exp 3/31/2028; AE5104, Exp 8/31/2028.
- Postal code
- 01887-1066
- Report date
- Jun 10, 2026
- Product type
- Drugs
- Recall number
- D-0554-2026
- Classification
- Class II
- Recalling firm
- Spectra Medical Devices, Llc
- Product quantity
- 210625 ampules
- Reason for recall
- Lack of Assurance of Sterility
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1.
- Distribution pattern
- USA Nationwide
- Recall initiation date
- May 12, 2026
- Initial firm notification
- Letter
- Center classification date
- Jun 2, 2026